Ethyl Pyruvate Inhibits Retinal Pathogenic Neovascularization by Downregulating HMGB1 Expression

Retinal pathogenic angiogenesis in the eyes is a causative factor in retinopathy of prematurity, diabetic retinopathy, and age-related macular degeneration. This study was designed to examine the pathogenic role of the high-mobility group box-1 (HMGB1) protein and the inhibitory effect of ethyl pyru...

Full description

Saved in:
Bibliographic Details
Main Authors: Yun Mi Lee, Junghyun Kim, Kyuhyung Jo, So Dam Shin, Chan-Sik Kim, Eun Jin Sohn, Seon Gi Kim, Jin Sook Kim
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2013/245271
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849305945446809600
author Yun Mi Lee
Junghyun Kim
Kyuhyung Jo
So Dam Shin
Chan-Sik Kim
Eun Jin Sohn
Seon Gi Kim
Jin Sook Kim
author_facet Yun Mi Lee
Junghyun Kim
Kyuhyung Jo
So Dam Shin
Chan-Sik Kim
Eun Jin Sohn
Seon Gi Kim
Jin Sook Kim
author_sort Yun Mi Lee
collection DOAJ
description Retinal pathogenic angiogenesis in the eyes is a causative factor in retinopathy of prematurity, diabetic retinopathy, and age-related macular degeneration. This study was designed to examine the pathogenic role of the high-mobility group box-1 (HMGB1) protein and the inhibitory effect of ethyl pyruvate (EP), a well-known antioxidant substance, in retinal pathogenic angiogenesis in mice with oxygen-induced retinopathy (OIR), one of the animal models of proliferative ischemic retinopathy. The OIR mouse model was used for our in vivo studies. The mice were exposed to 75% oxygen from postnatal day 7 (P7) to P11, after which the mice were brought to room air and intraperitoneally injected with EP (50 mg/kg, or 100 mg/kg) for five days. At P17, the mice were perfused with fluorescein isothiocyanate-dextran, and flat-mounted retinas were used to measure nonperfused and neovascular tufts. In OIR mice, an intraperitoneal injection of EP reduced the nonperfused retinal area in the treatment group and significantly reduced the retinal neovascular tufts. In addition, EP inhibited the overexpression of HMGB1 in the retinas of OIR mice. These data suggest that EP could serve as an innovative pharmaceutical agent to prevent retinal neovascularization through inhibiting HMGB1 expression.
format Article
id doaj-art-2f0d8ffd715e462bbd6e2e1405ed42e7
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-2f0d8ffd715e462bbd6e2e1405ed42e72025-08-20T03:55:16ZengWileyJournal of Diabetes Research2314-67452314-67532013-01-01201310.1155/2013/245271245271Ethyl Pyruvate Inhibits Retinal Pathogenic Neovascularization by Downregulating HMGB1 ExpressionYun Mi Lee0Junghyun Kim1Kyuhyung Jo2So Dam Shin3Chan-Sik Kim4Eun Jin Sohn5Seon Gi Kim6Jin Sook Kim7Korean Medicine Based Herbal Drug Development Group, Herbal Medicine Research Division, Korea Institute of Oriental Medicine (KIOM), 1672 Yuseongdaero, Yuseong-gu, Daejeon 305-811, Republic of KoreaKorean Medicine Based Herbal Drug Development Group, Herbal Medicine Research Division, Korea Institute of Oriental Medicine (KIOM), 1672 Yuseongdaero, Yuseong-gu, Daejeon 305-811, Republic of KoreaKorean Medicine Based Herbal Drug Development Group, Herbal Medicine Research Division, Korea Institute of Oriental Medicine (KIOM), 1672 Yuseongdaero, Yuseong-gu, Daejeon 305-811, Republic of KoreaKorean Medicine Based Herbal Drug Development Group, Herbal Medicine Research Division, Korea Institute of Oriental Medicine (KIOM), 1672 Yuseongdaero, Yuseong-gu, Daejeon 305-811, Republic of KoreaKorean Medicine Based Herbal Drug Development Group, Herbal Medicine Research Division, Korea Institute of Oriental Medicine (KIOM), 1672 Yuseongdaero, Yuseong-gu, Daejeon 305-811, Republic of KoreaKorean Medicine Based Herbal Drug Development Group, Herbal Medicine Research Division, Korea Institute of Oriental Medicine (KIOM), 1672 Yuseongdaero, Yuseong-gu, Daejeon 305-811, Republic of KoreaKorean Medicine Based Herbal Drug Development Group, Herbal Medicine Research Division, Korea Institute of Oriental Medicine (KIOM), 1672 Yuseongdaero, Yuseong-gu, Daejeon 305-811, Republic of KoreaKorean Medicine Based Herbal Drug Development Group, Herbal Medicine Research Division, Korea Institute of Oriental Medicine (KIOM), 1672 Yuseongdaero, Yuseong-gu, Daejeon 305-811, Republic of KoreaRetinal pathogenic angiogenesis in the eyes is a causative factor in retinopathy of prematurity, diabetic retinopathy, and age-related macular degeneration. This study was designed to examine the pathogenic role of the high-mobility group box-1 (HMGB1) protein and the inhibitory effect of ethyl pyruvate (EP), a well-known antioxidant substance, in retinal pathogenic angiogenesis in mice with oxygen-induced retinopathy (OIR), one of the animal models of proliferative ischemic retinopathy. The OIR mouse model was used for our in vivo studies. The mice were exposed to 75% oxygen from postnatal day 7 (P7) to P11, after which the mice were brought to room air and intraperitoneally injected with EP (50 mg/kg, or 100 mg/kg) for five days. At P17, the mice were perfused with fluorescein isothiocyanate-dextran, and flat-mounted retinas were used to measure nonperfused and neovascular tufts. In OIR mice, an intraperitoneal injection of EP reduced the nonperfused retinal area in the treatment group and significantly reduced the retinal neovascular tufts. In addition, EP inhibited the overexpression of HMGB1 in the retinas of OIR mice. These data suggest that EP could serve as an innovative pharmaceutical agent to prevent retinal neovascularization through inhibiting HMGB1 expression.http://dx.doi.org/10.1155/2013/245271
spellingShingle Yun Mi Lee
Junghyun Kim
Kyuhyung Jo
So Dam Shin
Chan-Sik Kim
Eun Jin Sohn
Seon Gi Kim
Jin Sook Kim
Ethyl Pyruvate Inhibits Retinal Pathogenic Neovascularization by Downregulating HMGB1 Expression
Journal of Diabetes Research
title Ethyl Pyruvate Inhibits Retinal Pathogenic Neovascularization by Downregulating HMGB1 Expression
title_full Ethyl Pyruvate Inhibits Retinal Pathogenic Neovascularization by Downregulating HMGB1 Expression
title_fullStr Ethyl Pyruvate Inhibits Retinal Pathogenic Neovascularization by Downregulating HMGB1 Expression
title_full_unstemmed Ethyl Pyruvate Inhibits Retinal Pathogenic Neovascularization by Downregulating HMGB1 Expression
title_short Ethyl Pyruvate Inhibits Retinal Pathogenic Neovascularization by Downregulating HMGB1 Expression
title_sort ethyl pyruvate inhibits retinal pathogenic neovascularization by downregulating hmgb1 expression
url http://dx.doi.org/10.1155/2013/245271
work_keys_str_mv AT yunmilee ethylpyruvateinhibitsretinalpathogenicneovascularizationbydownregulatinghmgb1expression
AT junghyunkim ethylpyruvateinhibitsretinalpathogenicneovascularizationbydownregulatinghmgb1expression
AT kyuhyungjo ethylpyruvateinhibitsretinalpathogenicneovascularizationbydownregulatinghmgb1expression
AT sodamshin ethylpyruvateinhibitsretinalpathogenicneovascularizationbydownregulatinghmgb1expression
AT chansikkim ethylpyruvateinhibitsretinalpathogenicneovascularizationbydownregulatinghmgb1expression
AT eunjinsohn ethylpyruvateinhibitsretinalpathogenicneovascularizationbydownregulatinghmgb1expression
AT seongikim ethylpyruvateinhibitsretinalpathogenicneovascularizationbydownregulatinghmgb1expression
AT jinsookkim ethylpyruvateinhibitsretinalpathogenicneovascularizationbydownregulatinghmgb1expression